Back to mobile site

Piper Sandler Reiterates Overweight Rating on Arrowhead Pharma (ARWR)

August 15, 2024 8:45 AM EDT Send to a Friend
Piper Sandler analyst Edward A. Tenthoff reiterated an Overweight rating and $62.00 price target on Arrowhead ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login